UPDATE Guvernul confirmă soluția pentru ROMATSA: credit prin EximBank sau finanțare prin FRB

The Romanian government is considering temporary financing for ROMATSA through Exim Bank to prevent financial blockages after Pfizer halted key revenue streams. Discussions suggest a bridge financing mechanism until legal issues in Belgium are resolved. ROMATSA's management emphasizes that they do not seek state subsidies but a recoverable funding solution. The financial strain arises from a court ruling obligating Romania to pay Pfizer approximately 600 million euros, affecting ROMATSA's income collected via EUROCONTROL. Authorities assure that air traffic remains unaffected, but prolonged revenue blockage could severely impact liquidity.